Patient reported outcome measures in chronic obstructive pulmonary disease: Which to use?

被引:23
作者
Ekstrom, Magnus [1 ]
Sundh, Josefin [2 ]
Larsson, Kjell [3 ]
机构
[1] Lund Univ, Dept Clin Sci, Div Resp Med & Allergol, SE-22100 Lund, Sweden
[2] Univ Orebro, Sch Med Sci, Dept Resp Med, SE-70182 Orebro, Sweden
[3] Karolinska Inst, Natl Inst Environm Med, Lung & Airway Res, Stockholm, Sweden
关键词
COPD; PROM; Measurement; Dyspnea; Health status; Quality of Life; Exacerbation; QUALITY-OF-LIFE; MEASURE PHYSICAL-ACTIVITY; AIR-FLOW OBSTRUCTION; HEALTH SURVEY SF-36; REFRACTORY BREATHLESSNESS; LUNG-FUNCTION; SEVERE COPD; DYSPNEA; EXACERBATIONS; QUESTIONNAIRE;
D O I
10.1586/17476348.2016.1146595
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Patient-reported outcomes (PROs), such as symptoms and perceived health status, are essential in chronic obstructive pulmonary disease (COPD) for determining disease severity, impact on daily life, effect of treatment and recovery from exacerbations. This field has evolved rapidly and there are a plethora of instruments assessing different PROs.The aim of this review is to provide an understanding of the concept of PROs in COPD. The PROs reflect important aspects of COPD which have a direct impact on daily life. Common symptoms such as dyspnea, cough, phlegm, anxiety, fatigue, and pain and as well as physical function and the risk for and occurrence of acute exacerbations should be assessed both in the clinic and in research. Besides impact on daily life, some of the PROs are related to disease progress and mortality. Construction of composite variables including different disease specific and generic PROs provide a general estimation of health status.
引用
收藏
页码:351 / 362
页数:12
相关论文
共 93 条
  • [1] Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea
    Abernethy, AP
    Currow, DC
    Frith, P
    Fazekas, BS
    McHugh, A
    Bui, C
    [J]. BRITISH MEDICAL JOURNAL, 2003, 327 (7414): : 523 - 526
  • [2] Is The CAT Questionnaire Sensitive To Changes In Health Status In Patients With Severe COPD Exacerbations?
    Agusti, Alvar
    Soler, Juan J.
    Molina, Jesus
    Munoz, Maria Jose
    Garcia-Losa, Manuel
    Roset, Montserrat
    Jones, Paul W.
    Badia, Xavier
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 9 (05) : 492 - 498
  • [3] Ahmadi Z, 2015, EUR RESP J
  • [4] Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale
    Al-Shair, Khaled
    Muellerova, Hana
    Yorke, Janelle
    Rennard, Stephen I.
    Wouters, Emiel F. M.
    Hanania, Nicola A.
    Sharafkhaneh, Amir
    Vestbo, Jorgen
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2012, 10
  • [5] [Anonymous], 1960, BMJ-BRIT MED J, V2, P1665
  • [6] [Anonymous], 2011, COCHRANE HDB SYSTEMA
  • [7] ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    ANTHONISEN, NR
    MANFREDA, J
    WARREN, CPW
    HERSHFIELD, ES
    HARDING, GKM
    NELSON, NA
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) : 196 - 204
  • [8] Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research
    Banzett, Robert B.
    O'Donnell, Carl R.
    Guilfoyle, Tegan E.
    Parshall, Mark B.
    Schwartzstein, Richard M.
    Meek, Paula M.
    Gracely, Richard H.
    Lansing, Robert W.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (06) : 1681 - 1691
  • [9] Using Laboratory Models to Test Treatment Morphine Reduces Dyspnea and Hypercapnic Ventilatory Response
    Banzett, Robert B.
    Adams, Lewis
    O'Donnell, Carl R.
    Gilman, Sean A.
    Lansing, Robert W.
    Schwartzstein, Richard M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (08) : 920 - 927
  • [10] Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
    Bestall, JC
    Paul, EA
    Garrod, R
    Garnham, R
    Jones, PW
    Wedzicha, JA
    [J]. THORAX, 1999, 54 (07) : 581 - 586